Acceptability, tolerability and safety of the BRIGhTMIND trial: Connectivity-guided intermittent theta-burst stimulation versus F3- repetitive transcranial magnetic stimulation for treatment-resistant depression
F3-rTMS and cgiTBS are comparably safe, tolerable and highly acceptable interventions for treatment-resistant depression. BRIGhTMIND systematically collected data from a large sample, providing evidence to meet the information needs of patients, clinicians and policy makers.
Authors
- R. Hamish McAllister‐Williams (ORCID: https://orcid.org/0000-0001-9966-1834)
- Sudheer Lankappa
- Shaun Barber (ORCID: https://orcid.org/0000-0002-8073-2687)
- Ana Suazo Di Paola (ORCID: https://orcid.org/0000-0002-8523-8557)
- Micheal Kurkar
- C. Boutry (ORCID: https://orcid.org/0000-0002-6781-2201)
- Richard Morriss (ORCID: https://orcid.org/0000-0003-2910-4121)
- Paul M. Briley (ORCID: https://orcid.org/0000-0002-5372-6505)
- Lucy Webster (ORCID: https://orcid.org/0000-0001-9152-4990)
- Louise Thomson (ORCID: https://orcid.org/0000-0003-1736-7506)
- Mohamed Abdelghani (ORCID: https://orcid.org/0000-0002-9888-6588)
Institutions
- University of Nottingham (GB)
- University of Leicester (GB)
- Cumbria Northumberland Tyne and Wear NHS Foundation Trust (GB)
- Nottinghamshire Healthcare NHS Foundation Trust (GB)
- Pennine Care NHS Foundation Trust (GB)
- Nottingham Biomedical Research Centre (GB)
- Camden and Islington NHS Foundation Trust (GB)
Publication Details
- Journal
- Comprehensive Psychiatry
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1016/j.comppsych.2024.152544
- Citations
- 2
- Primary Topic
- Transcranial Magnetic Stimulation Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.49